Pacer Advisors Inc. Acquires 541,468 Shares of Cencora, Inc. $COR

Pacer Advisors Inc. boosted its holdings in Cencora, Inc. (NYSE:COR) by 2,682.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 561,655 shares of the company’s stock after acquiring an additional 541,468 shares during the quarter. Pacer Advisors Inc.’s holdings in Cencora were worth $189,699,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Sonoma Allocations LLC grew its stake in Cencora by 81.2% during the fourth quarter. Sonoma Allocations LLC now owns 1,337 shares of the company’s stock valued at $483,000 after acquiring an additional 599 shares in the last quarter. MV Capital Management Inc. bought a new position in Cencora in the fourth quarter valued at $122,000. Kovitz Investment Group Partners LLC increased its position in shares of Cencora by 728.5% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 34,067 shares of the company’s stock valued at $11,506,000 after purchasing an additional 29,955 shares during the last quarter. Vancity Investment Management Ltd purchased a new position in shares of Cencora during the fourth quarter worth approximately $248,000. Finally, T. Rowe Price Investment Management Inc. lifted its stake in Cencora by 160.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock worth $2,262,956,000 after purchasing an additional 4,123,795 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Price Performance

NYSE COR opened at $271.99 on Friday. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The business’s fifty day moving average price is $285.65 and its 200-day moving average price is $324.72. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The stock has a market capitalization of $52.92 billion, a price-to-earnings ratio of 20.86, a PEG ratio of 1.50 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora declared that its Board of Directors has authorized a stock repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its stock is undervalued.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s payout ratio is 18.40%.

Analysts Set New Price Targets

Several analysts have weighed in on COR shares. Robert W. Baird lowered their price objective on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Weiss Ratings lowered shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Leerink Partners restated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Morgan Stanley set a $342.00 target price on shares of Cencora in a research note on Friday, May 8th. Finally, Evercore set a $360.00 price target on Cencora in a research report on Wednesday, April 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $374.00.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.